can i take bpc 157 with sermorelin 101: How This Peptide Stimulates Natural Growth Hormone bpc 157 peptide and sermorelin

Study 2 (NCT 00435136) This study re-randomized 177 HIV-infected patients with lipodystrophy who completed EGRIFTA treatment in the Main Phase to receive either a 2 mg dose of EGRIFTA (1 mg/vial formulation) (N=92) or placebo (N=85) for an additional 26-week duration (1:1 randomization ratio)

Dey DK, Lissner L

The peptide's ability to enhance angiogenesis proves particularly valuable in poorly vascularized tissues like tendons, where limited blood supply typically impedes healing

They can also be a reasonable fit for patients who are not candidates for, or who decline, prescription pharmacotherapy and are looking for a lower-intensity option